We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Insulated Transport System Safeguards Transplant Hearts

By HospiMedica International staff writers
Posted on 23 Jan 2019
Print article
Image: The SherpaPak cardiac transport system (Photo courtesy of Paragonix).
Image: The SherpaPak cardiac transport system (Photo courtesy of Paragonix).
A new organ transport system protects small adult and pediatric donor hearts on their way to transplant recipients.

The Paragonix Technologies (Braintree, MA, USA) SherpaPak cardiac transport system (CTS) is a single-use storage unit designed to standardize donor heart preservation and transport during triage to the recipient patient. To maintain a cold storage temperature range of 4-8°C, SherpaPak combines an insulated double walled rigid storage canister, non-toxic disposable cold packs, and a cradle to immerse and suspend the heart in a cold storage fluid that provides thermal stability at ambient and extreme temperatures.

Features of the system include an inner organ canister with a volume of four liters, a suspension system that provides both physical and thermal protection to the heart, a real-time preservation temperature sensor, and connectors to cover most aorta sizes, allowing transport of both adult and pediatric hearts. A data logger monitors organ temperature during transport, and a Bluetooth connectivity app monitors, records, and downloads preservation temperature and storage times to handheld devices. The intended organ storage time is up to four hours, but thermal stability has been demonstrated for over 12 hours.

“Our effective product implementation plan, combined with a variety of clinical support tools tailored individually to each transplant center, have resulted in sustained clinical utilization of Paragonix SherpaPak cardiac transport system,” said Bill Edelman, chairman and CEO of Paragonix. “We believe that improving the utilization of donated hearts is critical to patients in end-stage heart failure who are desperate for this precious commodity.”

Approximately 3,500 heart transplants are performed every year in the world, more than half of which occur in the United States. Post-operation survival periods average 15 years.

Related Links:
Paragonix Technologies

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgical Table
STERIS 5085 SRT

Print article

Channels

Critical Care

view channel
Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri)

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more